5th Mar 2014 14:46
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Wednesday said company secretary Zoe Goulding exercised options over 958 shares pursuant to the SAYE Scheme at an exercise price of GBP3.7564 each.
Following the transaction, Goulding's interest is 12,891 shares or 0.015% of the current issued share capital.
Shares in the phama company were up 2.0% at 717.06 pence Wednesday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
DPH.L